Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

CorMedix Inc. (CRMD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
4.2300+0.2400 (+6.02%)
At close: 01:00PM EST
4.1500 -0.08 (-1.89%)
After hours: 03:17PM EST
Advertisement

CorMedix Inc.

300 Connell Drive
Suite 4200
Berkeley Heights, NJ 07922
United States
908 517 9500
https://www.cormedix.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees29

Key Executives

NameTitlePayExercisedYear Born
Dr. Matthew T. David M.D.Exec. VP & CFO471.41kN/A1978
Dr. Phoebe Mounts Esq., Ph.D.EVP, Gen. Counsel, Head of Regulatory, Compliance, Legal & Technical Operations and Sec.448.29kN/A1950
Ms. Elizabeth Masson-Hurlburt B.A.Exec. VP & Head of Clinical Operations393.42kN/A1979
Mr. Joseph Todisco MBACEO & DirectorN/AN/A1976
Donna UcciSr. VP & Head of Global QualityN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Corporate Governance

CorMedix Inc.’s ISS Governance QualityScore as of October 1, 2022 is 4. The pillar scores are Audit: 5; Board: 5; Shareholder Rights: 2; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement